Use of Alternative Medicine Among Outpatients in Dermatology and Primary Care Clinics

October 30, 2018 updated by: Maria Colavincenzo, Northwestern University
This study is to assess the practice of complementary and alternative medicine (CAM) for skin related conditions among patients in the Primary Care and Dermatology clinics.

Study Overview

Status

Completed

Conditions

Detailed Description

This study aims to determine the prevalence and characteristics complementary and alternative medicine (CAM) usage among Primary Care and Dermatology clinic patients through the use of an anonymous, self-completed written survey. This survey will assess the prevalence and regularity of CAM usage (with and without concurrent use of allopathic therapies), the reasons for CAM usage, perceived success with CAM usage, and socioeconomic status, in both Dermatology and Primary Care patients. We will then compare these elements of CAM usage between the two clinic patient populations.

Study Type

Observational

Enrollment (Actual)

75

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Illinois
      • Chicago, Illinois, United States, 60611
        • Northwestern University Department of Dermatology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients attending clinic appointments in dermatology and primary care clinics.

Description

Inclusion Criteria:

  • 18 years or older
  • Presents for a clinic appointment with a dermatologist or primary care physician
  • English-speaking

Exclusion Criteria:

  • Less than 18 years or older
  • Non-English speaking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Dermatology Clinic Patients
Patient attending dermatology clinics
Primary Clinic Patients
Patient attending primary care clinics

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of complementary and alternative medicine usage among patients in the clinics
Time Frame: 5 minutes to complete survey
At the clinic appointment, patients will be given a survey that asks about whether the patient uses complementary and alternative medicine for skin related issues.
5 minutes to complete survey

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Characteristics of the patients complementary and alternative medicine use
Time Frame: 5 minutes to complete survey
Patients who practice complementary and alternative medicine will be asked about what and how they practice their complementary and alternative medicine.
5 minutes to complete survey

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Northwestern University

Investigators

  • Principal Investigator: Maria Colavincenzo, MD, Northwestern University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2012

Primary Completion (Actual)

October 1, 2015

Study Completion (Actual)

October 1, 2015

Study Registration Dates

First Submitted

August 6, 2012

First Submitted That Met QC Criteria

August 7, 2012

First Posted (Estimate)

August 8, 2012

Study Record Updates

Last Update Posted (Actual)

November 1, 2018

Last Update Submitted That Met QC Criteria

October 30, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STU67142

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dermatologic Disorders

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe